论文部分内容阅读
目的探讨奥扎格雷钠联合神经节苷脂对急性脑梗死患者治疗效果。方法将120例脑梗死患者,随机分为治疗组(奥扎格雷钠联合神经节苷脂)60例和对照组(阿魏酸钠)60例。两组患者均于治疗前和治疗后进行神经功能评分,结合治疗后患者的病残程度评定临床疗效,进行临床观察。结果奥扎格雷钠联合神经节苷脂治疗组总有效率96.7%,明显优于对照组83.3%(P<0.01)。结论奥扎格雷钠联合神经节苷脂治疗急性脑梗死有较好效果。
Objective To investigate the therapeutic effect of ozagrel combined with gangliosides in patients with acute cerebral infarction. Methods A total of 120 patients with cerebral infarction were randomly divided into treatment group (60 patients with ozagrel and ganglioside) and control group (sodium ferulate) 60 patients. Two groups of patients before and after treatment of neurological function score, combined with the severity of the patient after treatment to assess the clinical efficacy of clinical observation. Results The total effective rate of ozagrel combined with ganglioside was 96.7%, which was significantly better than that of the control group (83.3%, P <0.01). Conclusion Ozagrel sodium combined with ganglioside in the treatment of acute cerebral infarction has a good effect.